[MPI] YoY Annualized Quarter Result on 30-Sep-2016 [#1]

Stock
[MPI] MALAYSIAN PACIFIC INDUSTRIES
Announcement Date
09-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2017
Quarter
30-Sep-2016 [#1]
Profit Trend
QoQ- 0.87%
YoY- -15.34%
Quarter Report
Latest QR
Upcoming QR
MPI's Result
MPI's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 1,476,388 1,655,024 1,550,536 1,432,036 1,546,580 1,310,880 1,322,488 1.85%
PBT 197,228 253,000 210,376 223,284 253,104 107,032 95,192 12.90%
Tax -23,692 -39,876 -35,068 -24,848 -15,840 -20,636 -10,176 15.11%
NP 173,536 213,124 175,308 198,436 237,264 86,396 85,016 12.62%
-
NP to SH 147,172 169,112 144,968 158,884 187,676 79,636 71,340 12.82%
-
Tax Rate 12.01% 15.76% 16.67% 11.13% 6.26% 19.28% 10.69% -
Total Cost 1,302,852 1,441,900 1,375,228 1,233,600 1,309,316 1,224,484 1,237,472 0.86%
-
Net Worth 1,298,082 1,225,538 1,154,750 1,025,793 940,279 764,854 739,499 9.82%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 76,022 76,002 75,970 60,787 60,785 53,141 37,826 12.33%
Div Payout % 51.66% 44.94% 52.40% 38.26% 32.39% 66.73% 53.02% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 1,298,082 1,225,538 1,154,750 1,025,793 940,279 764,854 739,499 9.82%
NOSH 209,884 209,884 209,884 189,961 189,955 189,790 189,130 1.74%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 11.75% 12.88% 11.31% 13.86% 15.34% 6.59% 6.43% -
ROE 11.34% 13.80% 12.55% 15.49% 19.96% 10.41% 9.65% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 776.82 871.04 816.39 753.86 814.18 690.70 699.25 1.76%
EPS 77.44 89.00 76.32 83.64 98.80 41.96 37.72 12.73%
DPS 40.00 40.00 40.00 32.00 32.00 28.00 20.00 12.24%
NAPS 6.83 6.45 6.08 5.40 4.95 4.03 3.91 9.73%
Adjusted Per Share Value based on latest NOSH - 189,961
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 740.96 830.62 778.18 718.70 776.19 657.90 663.72 1.85%
EPS 73.86 84.87 72.76 79.74 94.19 39.97 35.80 12.82%
DPS 38.15 38.14 38.13 30.51 30.51 26.67 18.98 12.33%
NAPS 6.5148 6.1507 5.7954 5.1482 4.719 3.8386 3.7114 9.82%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 9.14 12.14 13.38 7.80 6.62 5.66 2.59 -
P/RPS 1.18 1.39 1.64 1.03 0.81 0.82 0.37 21.31%
P/EPS 11.80 13.64 17.53 9.33 6.70 13.49 6.87 9.42%
EY 8.47 7.33 5.70 10.72 14.92 7.41 14.56 -8.62%
DY 4.38 3.29 2.99 4.10 4.83 4.95 7.72 -9.00%
P/NAPS 1.34 1.88 2.20 1.44 1.34 1.40 0.66 12.52%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 26/11/19 08/11/18 08/11/17 09/11/16 17/11/15 12/11/14 14/11/13 -
Price 11.00 10.80 14.20 7.80 7.35 5.15 2.88 -
P/RPS 1.42 1.24 1.74 1.03 0.90 0.75 0.41 22.99%
P/EPS 14.21 12.13 18.60 9.33 7.44 12.27 7.64 10.89%
EY 7.04 8.24 5.38 10.72 13.44 8.15 13.10 -9.82%
DY 3.64 3.70 2.82 4.10 4.35 5.44 6.94 -10.19%
P/NAPS 1.61 1.67 2.34 1.44 1.48 1.28 0.74 13.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment